These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4853604)

  • 1. Pharmacokinetics of single and multiple doses of phenytoin in man.
    Lund L; Alvan G; Berlin A; Alexanderson B
    Eur J Clin Pharmacol; 1974; 7(2):81-6. PubMed ID: 4853604
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of a single dose of phenytoin in man measured by radioimmunoassay.
    Robinson JD; Morris BA; Aherne GW; Marks V
    Br J Clin Pharmacol; 1975 Aug; 2(4):345-9. PubMed ID: 1233994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin prodrugs V: In vivo evaluation of some water-soluble phenytoin prodrugs in dogs.
    Varia SA; Stella VJ
    J Pharm Sci; 1984 Aug; 73(8):1080-7. PubMed ID: 6548519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
    Frey HH; Löscher W
    Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphenylhydantoin.
    Glazko AJ
    Pharmacology; 1972; 8(1):163-77. PubMed ID: 4630160
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration.
    Ehrnebo M
    J Pharm Sci; 1974 Jul; 63(7):1114-8. PubMed ID: 4853598
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenytoin on the clinical pharmacokinetics of amiodarone.
    Nolan PE; Marcus FI; Karol MD; Hoyer GL; Gear K
    J Clin Pharmacol; 1990 Dec; 30(12):1112-9. PubMed ID: 2273084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of drugs administered intramuscularly.
    Thomas J
    Aust Fam Physician; 1977 Aug; 6(8):925-34. PubMed ID: 921622
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of phenytoin following intravenous administration in epileptic patients.
    Gatti G; Perucca E; Caravaggi M; Poloni M; Frigo GM; Crema A
    Farmaco Prat; 1977 Sep; 32(9):470-4. PubMed ID: 908442
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.
    Kostenbauder HB; Rapp RP; McGovren JP; Foster TS; Perrier DG; Blacker HM; Hulon WC; Kinkel AW
    Clin Pharmacol Ther; 1975 Oct; 18(4):449-56. PubMed ID: 1100308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serum phenytoin levels by radioimmunoassay following single oral doses [proceedings].
    Aherne GW; Marks V; Morris BA; Robinson JD
    Br J Clin Pharmacol; 1975 Aug; 2(4):382P. PubMed ID: 1234011
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenytoin: pharmacokinetics and bioavailability.
    Gugler R; Manion CV; Azarnoff DL
    Clin Pharmacol Ther; 1976 Feb; 19(2):135-42. PubMed ID: 1261151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
    Vinçon G; Ploux D; Pehourcq F; Albin H
    J Pharmacol; 1983; 14(1):47-55. PubMed ID: 6834851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin cumulation profiles.
    Yuen GJ; Bell RD; Ludden TM
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):355-68. PubMed ID: 6665297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous phenytoin: clinical and pharmacokinetic aspects.
    Cranford RE; Leppik IE; Patrick B; Anderson CB; Kostick B
    Neurology; 1978 Sep; 28(9 Pt 1):874-80. PubMed ID: 567761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Kokwaro GO
    Br J Clin Pharmacol; 2002 Dec; 54(6):635-42. PubMed ID: 12492612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin cumulation kinetics.
    Allen JP; Ludden TM; Burrow SR; Clementi WA; Stavchansky SA
    Clin Pharmacol Ther; 1979 Oct; 26(4):445-8. PubMed ID: 487692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of phenytoin clearance by valproic acid in normal subjects.
    Frigo GM; Lecchini S; Gatti G; Perucca E; Crema A
    Br J Clin Pharmacol; 1979 Dec; 8(6):553-6. PubMed ID: 391257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma kinetics of diphenylhydantoin in dogs and cats.
    Roye DB; Serrano EE; Hammer RH; Wilder BJ
    Am J Vet Res; 1973 Jul; 34(7):947-50. PubMed ID: 4720682
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.